Ming‐Nan Lai
Impact in
- Nephrology top 10%
- Dialysis and Renal Disease Management
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Fungal Biology and Applications
Papers in
- Pharmacology 11
- Fungal Biology and Applications 10
- Microbial Natural Products and Biosynthesis 2
-
- Polysaccharides and Plant Cell Walls 5
- Co-authors
- Pau‐Chung Chen (4 shared papers)Jung-Der Wang (2 shared papers)Ying Chen (1 shared paper)Shuo‐Meng Wang (1 shared paper)Lean‐Teik Ng (9 shared papers)Chun‐Han Su (6 shared papers)Mei‐Kuang Lu (3 shared papers)Ting‐Jang Lu (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (2 papers)American Journal of Nephrology (2 papers)Cancer Epidemiology Biomarkers & Prevention (1 paper)PLoS ONE (1 paper)Journal of Natural Products (1 paper)
- Partner nations
- TaiwanUnited Kingdom
In The Last Decade
Ming‐Nan Lai
19 papers receiving 526 citations
Peers
Comparison fields: 5 of 84
- Nephrology 65
- Pharmacology 77
- Pharmacology 89
- Radiology, Nuclear Medicine and Imaging 114
- Complementary and alternative medicine 33
Countries citing papers authored by Ming‐Nan Lai
This map shows the geographic impact of Ming‐Nan Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Nan Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Nan Lai more than expected).
Fields of papers citing papers by Ming‐Nan Lai
This network shows the impact of papers produced by Ming‐Nan Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Nan Lai. The network helps show where Ming‐Nan Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Nan Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 190 | |
| 2 | 2014 | 59 | |
| 3 | 2020 | 53 | |
| 4 | 2018 | 46 | |
| 5 | 1997 | 34 | |
| 6 | 2021 | 29 | |
| 7 | 1999 | 26 | |
| 8 | 2019 | 19 | |
| 9 | 2018 | 18 | |
| 10 | 2020 | 14 | |
| 11 | 2023 | 13 | |
| 12 | 2021 | 9 | |
| 13 | 2006 | 6 | |
| 14 | 2017 | 6 | |
| 15 | 2006 | 4 | |
| 16 | Osteoporosis and Associated Risk Factors for Chronic Hemodialysis Patients | 2002 | 3 |
| 17 | 2023 | 3 | |
| 18 | 2010 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2021 | 0 |
About Ming‐Nan Lai
Ming‐Nan Lai is a scholar working on Pharmacology, Plant Science, Radiology, Nuclear Medicine and Imaging, Surgery and Nephrology, having authored 20 papers that have together received 538 indexed citations. Recurring topics across this work include Fungal Biology and Applications (10 papers), Polysaccharides and Plant Cell Walls (5 papers), Nephrotoxicity and Medicinal Plants (4 papers), Seaweed-derived Bioactive Compounds (3 papers), Dialysis and Renal Disease Management (3 papers), Chemical synthesis and alkaloids (2 papers), Microbial Natural Products and Biosynthesis (2 papers) and Complementary and Alternative Medicine Studies (2 papers). The work is most often cited by research in Nephrology (65 citations), Pharmacology (77 citations), Pharmacology (89 citations), Radiology, Nuclear Medicine and Imaging (114 citations) and Complementary and alternative medicine (33 citations). Ming‐Nan Lai has collaborated with scholars based in Taiwan and United Kingdom. Frequent co-authors include Pau‐Chung Chen, Jung-Der Wang, Ying Chen, Shuo‐Meng Wang, Lean‐Teik Ng, Chun‐Han Su, Mei‐Kuang Lu, Ting‐Jang Lu, Ching‐Heng Lin and Ming‐Ju Wu. Their work appears in journals such as JNCI Journal of the National Cancer Institute, American Journal of Nephrology, Cancer Epidemiology Biomarkers & Prevention, PLoS ONE and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.